Number (%) of patients reporting the most common* drug related adverse events during the treatment period
| Adverse event | FP 100 μ g twice daily (n=267) | FP 200 μ g twice daily (n=261) |
|---|---|---|
| *Most common defined as those affecting ⩾1% of either treatment group. | ||
| Any drug related: | 16 (6) | 16 (6) |
| Hoarseness/dysphonia | 4 (1) | 3 (1) |
| Pharyngitis/throat infection | 3 (1) | 2 (<1) |
| Candidiasis (mouth/throat) | 4 (1) | 6 (2) |
| Appetite disturbance | 3 (1) | 4 (2) |